Laboratorios Richmond (Argentina) Today
| RICH Stock | ARS 1,710 20.00 1.18% |
Performance16 of 100
| Odds Of DistressLess than 9
|
Laboratorios Richmond is trading at 1710.00 as of the 30th of November 2024, a 1.18 percent increase since the beginning of the trading day. The stock's open price was 1690.0. Laboratorios Richmond has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Laboratorios Richmond SACIF are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Laboratorios Richmond S.A.C.I.F. develops and manufactures pharmaceutical products for physicians, pharmacists, health institutions, and patients in Argentina and internationally. The company was founded in 1935 and is based in Buenos Aires, Argentina. The company has 14.17 M outstanding shares. More on Laboratorios Richmond SACIF
Moving together with Laboratorios Stock
Moving against Laboratorios Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Laboratorios Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Laboratorios Richmond's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Laboratorios Richmond or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Laboratorios Richmond SACIF (RICH) is traded on Buenos Aires Exchange in Argentina and employs 620 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 31.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Laboratorios Richmond's market, we take the total number of its shares issued and multiply it by Laboratorios Richmond's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Laboratorios Richmond operates under Healthcare sector and is part of Biotechnology industry. The entity has 14.17 M outstanding shares.
Laboratorios Richmond SACIF has accumulated about 348.26 M in cash with 3.73 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.31.
Check Laboratorios Richmond Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Laboratorios Richmond SACIF is 31.94 Billion. Roughly 99.66 % of Laboratorios Richmond outstanding shares are held by general public with 0.34 % by institutional investors. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Check Laboratorios Ownership Details
Laboratorios Richmond Risk Profiles
Although Laboratorios Richmond's alpha and beta are two of the key measurements used to evaluate Laboratorios Richmond's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.22 | |||
| Semi Deviation | 2.63 | |||
| Standard Deviation | 4.89 | |||
| Variance | 23.92 |
Laboratorios Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Laboratorios Richmond without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Other Information on Investing in Laboratorios Stock
Laboratorios Richmond financial ratios help investors to determine whether Laboratorios Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Laboratorios with respect to the benefits of owning Laboratorios Richmond security.